Diagnosis and management of labile blood pressure during acute cerebrovascular accidents and other hypertensive crises

American Journal of Emergency Medicine

Volumn 25, Issue 8, 2007, Pages 949-959

  Varon, Joseph ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ENALAPRIL; ESMOLOL; FENOLDOPAM; FIBRINOLYTIC AGENT; LABETALOL; NICARDIPINE; NITROPRUSSIDE SODIUM; PHENTOLAMINE;

BLOOD PRESSURE; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE TITRATION; EMERGENCY CARE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPERTENSION ENCEPHALOPATHY; LABORATORY TEST; MATERNAL HYPERTENSION; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SUBARACHNOID HEMORRHAGE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FIBRINOLYTIC AGENTS; HUMANS; HYPERTENSION; HYPERTENSION, MALIGNANT;

EID: 34848825598     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2007.02.032     Document Type: Review

References (96)

1. Goldstein L.B., Adams R., Alberts M.J., et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke 37 (2006) 1583-1633
2. Goldstein L.B., Adams R., Becker K., et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the stroke council of the American Heart Association. Stroke 32 (2001) 280-299
3. MacMahon S., Peto R., Cutler J., et al. Epidemiology blood pressure, stroke, and coronary heart disease. Lancet 335 (1990) 765-774
4. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
5. Brott T., and Bogousslavsky J. Treatment of acute ischemic stroke. N Engl J Med 343 (2000) 710-722
6. Varon J., and Marik P.E. Clinical review: the management of hypertensive crises. Crit Care 7 (2003) 374-384
7. Wallace J.D., and Levy L.L. Blood pressure after stroke. JAMA 246 (1981) 2177-2180
8. Britton M., Carlsson A., and De Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke 17 (1986) 861-864
9. Broderick J.P., Adams H.P., Barsan W., et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a Special Writing Group of the Stroke Council. American Heart Association. Stroke 30 (1999) 905-915
10. Powers W.J. Acute hypertension after stroke: the scientific basis for treatment decisions. Neurology 43 (1993) 461-467
11. Ohwaki K., Yano E., Hagashima H., et al. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 35 (2004) 1364-1367
12. Chalmers J. Trials on blood pressure-lowering and secondary stroke prevention. Am J Cardiol 91 10A (2003) 3G-8G
13. Suarez J.I., Tarr R.W., and Selman W.R. Anuerysmal subarachnoid hemorrhage. N Engl J Med 354 (2006) 387-396
14. Talbert R.L. The challenge of blood pressure management in neurologic emergencies. Pharmacotherapy 26 8 pt 2 (2006) 123S-130S
15. Goldstein L.B. Blood pressure management in patients with acute ischemic stroke. Hypertension 43 (2004) 137-141
16. Oliveira-Filho J., Silva S.C.S., Trabuco C.C., et al. Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology 61 (2003) 1047-1051
17. Adams H.P., Adams R.J., Brott T., et al. Guidelines for the early management of patients with ischemic stroke. A scientific statement from the Stroke Council of the American Stroke Association. Stroke 34 (2003) 1056-1083
18. Adams H., Adams R., Del Zoppo G., et al. Guidelines for the early management of patients with ischemic stroke, 2005 guidelines update. A scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 36 (2005) 916-921
19. Cook D.J., Guyatt G.H., Laupacis A., et al. Clinical recommendations using levels of evidence from antithrombotic agents. Chest 108 (1995) 227-230
20. Oxford-Centre for Evidence-Based Medicine. Levels of evidence and grades of recommendations. Available at:. http://www.cebm.net/levels_of_evidence.asp [Accessed 30 January 2007]
21. Feigin V.L., Lawes C.M.M., Bennett D.A., et al. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neural 2 (2003) 43-53
22. Thom T., Haase N., Rosamond W., et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 (2006) 85-151
23. Brown D.J., and Metiko E.B. Prevalence of hypertension in a sample of black American adults using JNC 7 classifications. J Natl Black Nurses Assoc 16 (2005) 1-5
24. Cooper R.S., Liao Y., and Rotimi C. Is hypertension more severe among U.S. blacks, or is severe hypertension more common?. Ann Epidemiol 6 (1996) 173-180
25. National Center for Health Statistics. Health, United States, 2005 with chartbook on the trends of the health of Americans. Centers for Disease Control Web site. Available at:. http://www.cdc.gov/nchs/data/hus/hus05.pdf#069 [Accessed 5 September 2006]
26. Wang T.J., and Vasan R.S. Epidemiology of uncontrolled hypertension in the United States. Circulation 112 (2005) 1651-1662
27. Calhoun D.A., and Oparil S. Treatment of hypertensive crisis. N Engl J Med 323 (1990) 1177-1183
28. Varon J., and Marik P.E. The diagnosis and management of hypertensive crises. Chest 118 (2000) 214-227
29. Kearney P.M., Whelton M., Reynolds K., et al. Global burden of hypertension: analysis of worldwide data. Lancet 365 (2005) 217-223
30. Sharp F.R., Swanson R.A., Honkaniemi J., et al. Neurochemistry and molecular biology. In: Barnett H.J.M., Mohr J.P., Stein B.M., et al. (Eds). Stroke pathophysiology, diagnosis, and management. 3rd ed. (1998), Churchill Livingstone, New York, NY 51-83
31. Siesjo B.K., Katsura K., Zhao Q., et al. Mechanisms of secondary brain damage in global and focal ischemia: a speculative synthesis. J Neurotrauma 12 (1995) 943-956
32. Foulkes M.A., Wolf P.A., Price T.R., et al. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 1 (1988) 547-554
33. Brisman J.L., Song J.K., and Newell D.W. Cerebral aneurysms. N Engl J Med 355 (2006) 928-939
34. Greenberg M.S. SAH and aneurysms. In: Greenberg M.S. (Ed). Handbook of neurosurgery. 5th ed. (2000), Thieme Medical, New York (NY) 754-803
35. Mergenthaler P., Dirnagl U., and Meisel A. Pathophysiology of stroke: lessons from animal models. Metab Brain Dis 19 (2004) 151-167
36. Ropper A.H., and Brown R.H. Cerebrovascular disease. In: Victor M., and Ropper A.H. (Eds). Adams and Victor's principles of neurology. 8th ed. (2005), The McGraw-Hill Companies, Inc, New York (NY) 660-746
37. Whitworth J.A., World Health Organization, and International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21 (2003) 1983-1992
38. Kaplan N.M. Hypertensive crises. In: Kaplan N.M. (Ed). Kaplan's clinical hypertension. 9th ed. (2006), Lippincott Williams & Wilkins, Philadelphia (PA) 311-324
39. Kitiyakara C., and Guzman N.J. Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol 9 (1998) 133-142
40. Oparil S., Aronson S., Deeb G.M., et al. Fenoldopam: a new parenteral antihypertensive-consensus roundtable on the management of perioperative hypertension and hypertensive crises. Am J Hypertens 12 (1999) 653-664
41. Tisdale J.E., Huang M.B., and Borzak S. Risk factors for hypertensive crisis: importance of out-patient blood pressure control. Fam Pract 21 (2004) 420-424
42. Shea S., Misra D., Ehrlich M.H., et al. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med 327 (1992) 776-781
43. Savvidou M.D., Hingorani A.D., Tsikas D., et al. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361 (2003) 1511-1517
44. Chodera A., Konkiewicz B., Nowadowska E., et al. The effect of tricyclic antidepressants (TA) on the circulatory system in primary arterial hypertension. Int J Clin Pharmacol Biopharm 17 (1979) 299-302
45. Schimmer B.P., and Parker K.L. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman J.G., and Limbird L.E. (Eds). Goodman & Gilman's the pharmacological basis of therapeutics. 10th ed. (2001), McGraw-Hill, New York (NY) 1649-1677
46. Shiozaki T. Hypertension and head injury. Curr Hypertens Rep 7 (2005) 450-453
47. Leonardi-Bee J., Bath P.M.W., Phillips S.J., et al. Blood pressure and clinical stroke outcomes in the International Stroke Trial. Stroke 33 (2002) 1315-1320
48. Halpern N.A., Coldbery M., Neely C., et al. Postoperative hypertension: a multicenter, prospective, randomized comparison between intravenous nicardipine and sodium nitroprusside. Crit Care Med 20 (1992) 1637-1643
49. Gal T.J., and Cooperman L.H. Hypertension in the immediate postoperative period. Br J Anaesth 47 (1975) 70-74
50. Levy J.H. Treatment of perioperative hypertension. Anesthesiol Clin North Am 17 (1999) 567-579
51. Curran M.P., Robinson D.M., and Keating G.M. Intravenous nicardipine its use in the short-term treatment of hypertension and various other indications. Drugs 66 (2006) 1755-1782
52. Duley L., Meher S., and Abalos E. Management of pre-eclampsia. BMJ 332 (2006) 463-468
53. Carbonne B., Jannet D., Touboul C., et al. Nicardipine treatment of hypertension in pregnancy. Obstet Gynecol 81 (1993) 908-914
54. Mackay A.P., Berg C.J., and Atrash H.K. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 97 (2001) 533-538
55. Dinsdale H.B. Hypertensive encephalopathy. Neurol Clin 1 (1983) 3-16
56. Chester E.M., Agamanolis D.P., Banker B.Q., and Victor M. Hypertensive encephalopathy: a clinicopathologic study of 20 cases. Neurology 28 9 pt 1 (1978) 928-939
57. Khan I.A., and Nair C.K. Clinical, diagnostic, and management perspectives of aortic dissection. Chest 122 (2002) 311-328
58. Hickler R.B. "Hypertensive emergency": a useful diagnostic category. Am J Publ Health 78 (1988) 623-624
59. Ault M.J., and Ellrodt A.G. Pathophysiological events leading to the end-organ effects of acute hypertension. Am J Emerg Med 3 6 Suppl (1985) 10-15
60. Wallach R., Karp R.B., Reves J.G., et al. Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: a study of hemodynamic and humoral factors. Am J Cardiol 46 (1980) 559-565
61. Strandgaard S. Autoregulation of cerebral blood flow in hypertensive patients. Circulation 53 (1976) 720-727
62. Strandgaard S. Autoregulation of brain circulation in severe arterial hypertension. BMJ 1 (1973) 507-510
63. Harper A.M., Lassen N.A., MacKenzie E.T., et al. Proceedings: the upper limit of "autoregulation" of cerebral blood flow in the baboon. J Physiol 234 (1973) 61P-62P
64. Blumenfeld J.D., and Laragh J.H. Management of hypertensive crises: the scientific basis for treatment decisions. Am J Hypertens 1 (2001) 1154-1167
65. Touyz R.M. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?. Hypertension 4 (2004) 248-252
66. Patel H.P., and Mitsnefes M. Advances in the pathogenesis and management of hypertensive crisis. Curr Opin Pediatr 17 (2005) 210-214
67. Lip G.Y., Edmunds E., Hee F., et al. A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension. Am J Hypertens 14 (2001) 823-828
68. Wahl M., and Schilling L. Regulation of cerebral blood flow-a brief review. Acta Neurochir Suppl (Wien) 59 (1993) 3-10
69. Rose J.C., and Mayer S.A. Optimizing blood pressure in neurological emergencies. Neurocrit Care 3 (2004) 287-300
70. Chamorro A., Vila N., Ascaso C., et al. Blood pressure and functional recovery in acute ischemic stroke. Stroke 29 (1998) 1850-1853
71. Reinhard M., Roth M., Guschlbauer B., et al. Dynamic cerebral autoregulation in acute ischemic stroke assessed from spontaneous blood pressure fluctuations. Stroke 36 (2005) 1684-1689
72. Elliott W.J. Clinical features in the management of selective hypertensive emergencies. Prog Cardiovasc Dis 48 (2006) 316-325
73. Tuncel M., and Ram V.C. Hypertensive emergencies. Etiology and management. Am J Cardiovasc Drugs 3 (2003) 21-31
74. Fenves A.Z., and Ram C.V. Drug treatment of hypertensive urgencies and emergencies. Semin Nephrol 25 (2005) 272-280
75. Migneco A., Ojetti V., De Lorenzo A., et al. Hypertensive crises: diagnosis and management in the emergency room. Eur Rev Med Pharmacol Sci 8 (2004) 143-152
76. Sunshine J.L., and Tarr R.W. Neuroimaging in neuroemergencies. In: Suarez J.I. (Ed). Critical care neurology and neurosurgery (2004), Humana Press, Totowa (NJ) 123-135
77. Wall S.D., Brandt-Zawadzki M., Jeffrey R.B., et al. High frequency CT findings within 24 hours after cerebral infarction. AJR Am J Roentgenol 138 (1982) 307-311
78. Yuh W.T., Crain M.R., Loes D.J., et al. MR imaging of cerebral ischemia: findings in the first 24 hours. AJNR Am J Neuroradiol 12 (1991) 621-629
79. Bryan R.N., Levy L.M., Whitlow W.D., et al. Diagnosis of acute cerebral infarction: comparison of CT and MRI imaging. AJNR Am J Neuroradiol 12 (1991) 611-620
80. MR-Technology. Apparent diffusion coefficient. MR-Technology Web site. Available at:. http://www.mr-tip.com/serv1.php?type=db1&dbs=Apparent%20Diffusion%20 Coefficient [Accessed 6 September 2006]
81. Hand P.J., Wardlaw J.M., Rivers C.S., et al. MR diffusion-weighted imaging and outcome prediction after ischemic stroke. Neurology 66 (2006) 1159-1163
82. Schaefer P.W., Copen W.A., Lev M.H., et al. Diffusion-weighted imaging in acute stroke. Magn Reson Imaging Clin N Am 14 (2006) 141-168
83. Le Bihan D., Turner R., Douek P., et al. Diffusion MR imaging: clinical applications. AJR Am J Roentgenol 159 (1992) 591-599
84. Rosen B.R., Belliveau J.W., Vevea J.M., et al. Perfusion imaging with NMR contrast agents. Magn Reson Med 14 (1990) 249-265
85. Schlaug G., Benfield A., Baird A.E., et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology 53 (1999) 1528-1537
86. Lovblad K.O., El-Koussy M., Oswald H., et al. Magnetic resonance imaging of the ischaemic penumbra. Swiss Med Wkly 133 (2003) 551-559
87. Cardene IV (nicardipine hydrochloride) [package insert] (2006), Baxter Healthcare Corporation, Deerfield (IL)
88. Trandate (labetalol hydrochloride) [package insert] (2003), Prometheus Laboratories, San Diego (CA)
89. Rhoney D.H., and Liu-DeRyke X. Effect of vasoactive therapy on cerebral circulation. Crit Care Clin 22 (2006) 221-243
90. Neutel J.M., Smith D.H.G., Wallin D., et al. A comparison of intravenous nicardipine and sodium nitroprusside in the immediate treatment of severe hypertension. Am J Hypertens 7 (1994) 623-628
91. Rodriguez G., and Varon J. Clevidipine: a unique agent for the critical care practitioner. Crit Care & Shock 9 (2006) 37-41
92. Eames P.J., Blake M.J., Dawson S.L., et al. Dynamic cerebral autoregulation and beat to beat blood pressure control are impaired in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 72 (2002) 467-472
93. Dawson S.L., Panerai R.B., and Potter J.F. Serial changes in static and dynamic cerebral autoregulation after acute ischaemic stroke. Cerebrovasc Dis 16 (2003) 69-75
94. Marshall R.S. The functional relevance of cerebral hemodynamics: why blood flow matters to the injured and recovering brain. Curr Opin Neurol 17 (2004) 705-709
95. American Heart Association. 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 112 Suppl 1 (2005) IV1-IV211
96. Schrader J., Luders S., Kulschewski A., et al. The ACCESS study evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke 34 (2003) 1699-1703